The company currently has more than 10 varieties under research, mainly including DPT series combined vaccines, Hand-foot-mouth series vaccines, Pneumococcal series vaccines, MMR series live attenuated vaccine, Hepatitis B vaccine, Sabin strain inactivated polio vaccine, etc. These varieties will be successively listed over the next few years, serving China and even the global disease prevention and control.